We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.918 USD 0.03 ( 2.85%)
Last update at 2026-11-12T15:42:00Z
VOLUME
15456
Market Cap
4.67M

Momentum Score

…

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice. The company was incorporated in 2004 and is headquartered in Surprise, Arizona.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.92
Low
0.99
High
52 Week Price Range
0.82
Low
5.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

SenesTech, Inc. develops and commercializes non-lethal fertility-control products for pest rodents, marketed to pest managers, municipalities and facility operators. Long-term growth may be driven by adoption of non-toxic control methods, regulatory approvals and geographic expansion, and recurring service revenue; investors may view this as exposure to an IP-backed alternative to conventional rodenticides.
Primary risk is limited commercial scale and dependence on a single product, which creates adoption, regulatory and financing vulnerability.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.89
Dividend Yield
-
Revenue TTM
2.37M
Revenue Per Share
0.46
Gross Profit TTM
1.57M
Debt / Equity
0.28
ROE
-107.42%
Net Debt
-4.90M
ROCE
-52.81%
Diluted EPS TTM
-0.61

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -6.38M -6.18M -7.71M -9.70M -8.27M
Net income -6.38M -6.18M -7.71M -9.71M -7.98M
Selling general administrative 5.93M 5.25M 6.70M 7.59M 7.22M
Selling and marketing expenses 0.26M 0.29M 0.32M 0.63M -
Gross profit 1.39M 1.00M 0.54M 0.46M 0.22M
Reconciled depreciation 0.14M 0.16M 0.14M 0.18M 0.30M
Ebit -6.36M -6.16M -7.71M -9.67M -8.93M
Ebitda -6.23M -6.01M -7.57M -9.69M -8.93M
Depreciation and amortization 0.14M 0.16M 0.14M -0.02M 0.00M
Operating income -6.50M -6.25M -7.73M -9.67M -8.93M
Other operating expenses 8.73M 8.11M 8.93M 10.69M 9.51M
Interest expense 0.02M 0.02M 0.00M 0.00M 0.01M
Interest income 0.14M 0.06M 0.02M 0.01M 0.00M
Net interest income 0.12M 0.03M 0.02M 0.01M -0.01M
Income tax expense - - 0.03M 0.02M -0.29M
Total revenue 2.22M 1.86M 1.19M 1.02M 0.58M
Total operating expenses 7.89M 7.25M 8.27M 10.14M 9.15M
Cost of revenue 0.83M 0.85M 0.65M 0.56M 0.36M
Total other income expense net 0.12M 0.07M 0.02M -0.02M 0.67M
Net income from continuing ops -6.38M -6.18M -8.12M -9.70M -8.27M
Net income applicable to common shares - - - -9.70M -8.27M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 12.84M 3.28M 7.29M 6.78M 11.50M
Other current assets 0.30M 0.38M 0.39M 0.38M 0.25M
Total liab 3.27M 0.77M 0.94M 1.50M 1.47M
Total stockholder equity 9.57M 2.51M 6.35M 5.28M 10.04M
Other current liab 0.38M 0.28M 0.37M 0.56M 0.58M
Common stock 0.01M 0.00M 0.01M 0.00M 0.01M
Capital stock 0.01M 0.00M 0.01M 0.00M 0.01M
Retained earnings -142.48M -136.10M -129.91M -122.20M -112.51M
Other assets - - - 0.02M 0.02M
Cash 7.58M 1.31M 5.39M 4.78M 9.33M
Total current liabilities 0.80M 0.56M 0.79M 1.32M 0.94M
Current deferred revenue 0.03M 0.01M 0.02M 0.04M -
Net debt -4.90M -1.04M -4.99M -4.42M -8.77M
Short term debt 0.20M 0.06M 0.25M 0.18M 0.03M
Short long term debt 0.06M 0.06M 0.03M - 0.03M
Short long term debt total 2.68M 0.26M 0.41M 0.36M 0.56M
Other stockholder equity 152.04M 138.61M 136.26M 127.48M 122.53M
Property plant equipment - - - 0.64M 0.84M
Total current assets 10.06M 2.81M 6.67M 6.12M 10.66M
Net tangible assets - - - 5.28M 10.04M
Short term investments 0.99M 0.00M - - -
Net receivables 0.20M 0.34M 0.10M 0.11M 0.08M
Long term debt 0.14M 0.21M 0.16M - -
Inventory 0.99M 0.79M 0.80M 0.85M 1.00M
Accounts payable 0.18M 0.21M 0.15M 0.54M 0.33M
Accumulated other comprehensive income - - 0.00M - -
Non currrent assets other 0.04M 0.06M 0.02M 0.02M -
Non current assets total 2.78M 0.47M 0.62M 0.66M 0.84M
Capital lease obligations 2.47M 0.00M 0.22M 0.36M 0.52M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -0.96M -0.06M -0.12M -0.17M -0.10M
Change to liabilities - - - 0.25M -0.07M
Total cashflows from investing activities -1.10M -0.06M -0.15M -0.17M -0.10M
Net borrowings -0.06M -0.02M 0.11M -0.03M -0.09M
Total cash from financing activities 13.12M 2.00M 8.34M 4.20M 13.56M
Change to operating activities - - - -0.17M 0.25M
Net income -6.38M -6.18M -7.71M -9.70M -8.27M
Change in cash 6.27M -4.09M 0.62M -4.55M 5.68M
Begin period cash flow 1.31M 5.39M 4.78M 9.33M 3.64M
End period cash flow 7.58M 1.31M 5.39M 4.78M 9.33M
Total cash from operating activities -5.75M -6.03M -7.57M -8.58M -7.78M
Issuance of capital stock 2.71M 0.04M 7.23M 4.23M 12.42M
Depreciation 0.14M 0.16M 0.14M 0.18M 0.30M
Other cashflows from investing activities 2.00M 0.03M - - -
Change to inventory -0.20M 0.00M 0.06M 0.15M -0.06M
Change to account receivables 0.12M -0.24M 0.02M -0.04M -0.05M
Sale purchase of stock - - -0.01M - -
Other cashflows from financing activities 13.12M 1.98M 2.82M -0.17M 1.23M
Change to netincome - - - 0.74M 0.12M
Capital expenditures 0.14M 0.08M 0.15M 0.17M 0.10M
Change in working capital 0.12M -0.30M -0.54M 0.19M 0.07M
Stock based compensation 0.26M 0.33M 0.56M 0.71M 0.77M
Other non cash items 0.12M -0.03M -0.00M 0.03M -0.65M
Free cash flow -5.89M -6.12M -7.71M -8.75M -7.88M

Peer Comparison*

Sector: Basic Materials Industry: Specialty Chemicals

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SNES
SenesTech Inc
0.03
2.85%
0.92 - 3.40 1.92 0.77 0.91 0.11
LIN
Linde plc Ordinary Shares
-0.71
0.13%
525.84 33.77 28.90 6.56 5.42 7.03 18.92
AIQUY
Air Liquide SA ADR
-0.01
0.02%
42.70 30.69 24.81 4.70 4.10 4.36 15.61
AIQUF
L'Air Liquide S.A
0.01
0.00%
213.36 29.78 22.68 4.54 3.98 4.50 15.90
SHW
Sherwin-Williams Co
0.06
0.02%
355.82 33.33 27.40 3.38 20.60 3.88 21.36

Profile*

SenesTech Inc

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice. The company was incorporated in 2004 and is headquartered in Surprise, Arizona.

13430 North Dysart Road, Surprise, AZ, United States, 85379

928 779 4143

23

Name Title Year Born
Mr. Thomas C. Chesterman M.B.A. Exec. VP, CFO, Treasurer & Assistant Sec. 1959
Dr. Steven C. Krause Ph.D. Exec. VP of Sales & Marketing 1960
Mr. Kenneth S. Siegel Exec. Director 1956
Mr. Joel Fruendt CEO & Director 1961
Ms. Kim Patrice Wolin Exec. VP of Operations & Sec. 1955
Ms. Nicole Williams Chief Strategy Officer 1980
Mr. Paul M. Palz VP & Corp. Controller NA
Robert Blum Investor Relations NA
Mr. Joel L. Fruendt CEO, President & Director 1961
Mr. Thomas C. Chesterman M.B.A. Executive VP, CFO, Treasurer & Secretary 1959

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…